WO2007028987A2 - Appareil et procede de separation de matiere a partir d'echantillons biologiques - Google Patents

Appareil et procede de separation de matiere a partir d'echantillons biologiques Download PDF

Info

Publication number
WO2007028987A2
WO2007028987A2 PCT/GB2006/003299 GB2006003299W WO2007028987A2 WO 2007028987 A2 WO2007028987 A2 WO 2007028987A2 GB 2006003299 W GB2006003299 W GB 2006003299W WO 2007028987 A2 WO2007028987 A2 WO 2007028987A2
Authority
WO
WIPO (PCT)
Prior art keywords
vessel
closure member
sample
channel
exit port
Prior art date
Application number
PCT/GB2006/003299
Other languages
English (en)
Other versions
WO2007028987A3 (fr
Inventor
Osborn Jones
Original Assignee
Gwernafalau Cyfyngedig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gwernafalau Cyfyngedig filed Critical Gwernafalau Cyfyngedig
Priority to EP06779318A priority Critical patent/EP1938108A2/fr
Publication of WO2007028987A2 publication Critical patent/WO2007028987A2/fr
Publication of WO2007028987A3 publication Critical patent/WO2007028987A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/25—Mixers with loose mixing elements, e.g. loose balls in a receptacle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50853—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates with covers or lids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1079—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices with means for piercing stoppers or septums
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02—Adapting objects or devices to another
    • B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/046—Function or devices integrated in the closure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0681—Filter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • B01L2400/049—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics vacuum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/06—Valves, specific forms thereof
    • B01L2400/0605—Valves, specific forms thereof check valves
    • B01L2400/0616—Ball valves
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00465—Separating and mixing arrangements
    • G01N2035/00534—Mixing by a special element, e.g. stirrer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N2035/1027—General features of the devices
    • G01N2035/1048—General features of the devices using the transfer device for another function
    • G01N2035/1053—General features of the devices using the transfer device for another function for separating part of the liquid, e.g. filters, extraction phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1009—Characterised by arrangements for controlling the aspiration or dispense of liquids

Definitions

  • the present invention relates to apparatus and a method of separating material from a biological sample, the sample is in particular but not exclusively, biological cells, with the material that is separated being a nucleic acid.
  • the separation and extraction of nucleic acids such as DNA or RNA from cells is well known.
  • Manual extraction where a technician uses a hand held pipette holder, is one way of extracting nucleic acids.
  • Such a method may involve using microplates having an array of open wells or tubes, which can receive a sample.
  • a lysis buffer is added to, each well using a disposable pipette tip.
  • Multiple samples can be treated using a pipette holder having a series of pipettes arranged in a linear array on the holder.
  • a biological cell sample containing nucleic acid is then added to the wells using a disposable pipette tip.
  • the sample is mixed with a solid substrate such as a number of magnetic beads that can bind with the nucleic acid that has been released from the cells and the sample is incubated.
  • the nucleic acid and solid substrate complex is then attracted using a magnetic field to confine the complex within an area of the extraction apparatus so that it can be removed from extraneous contaminants such as haemoglobin and other proteins .
  • Another disposable pipette is used for each sample, to separate buffer and the contaminants from the resulting nucleic acid/solid substrate complex.
  • the complex is washed a number of times, usually four or more times, using a fresh disposable pipette tip each time and for each sample. There may even be the step of transferring the complex to a further microplate so that further washing may occur to remove contaminants .
  • each microplate remains open during the process, there is the risk of aerosols being generated, when the sample is agitated by material being sucked in and out of the pipette, which, if pathogens or hazardous reagents are being used, could endanger the health of the technician and can pollute the environment.
  • Automated separation and extraction methods follow the steps of manual separation and extraction, with the microplates being held in an accessible platform such as a tray or carousel or a chamber. Automation can increase the risk of the generation of aerosols, especially if using open trays and there is the technical difficulty of alignment of the pipette tips with the wells by a machine. Also, unlike a human operator, during an automated operation, it is not so easy to visually check that the method is being carried out properly for example, when the nucleic acid/solid complex sample is being re-suspended, the human eye is the best judge of when to start this re-suspension procedure.
  • the best point to carry this out is when the complex has been successfully attracted to the orifice of a pipette tip and the point at which this occurs can best be judged by the human eye.
  • the re-suspension may start when the sample is not in proximity to the pipette tip, which could result in a sample where the nucleic acid is not properly re-suspended.
  • Microplates can have eight or twelve rows of open wells or tubes, and fresh disposable plastic pipette tips are used at each stage of the processing of the sample, this means that there is a great deal of wastage of plastic material. Also, as the plastic components are simply disposed of once used, there is the likelihood of environmental contamination occurring by reagents or nucleic acid material that remains on the disposed components. The more components that are disposed of then there is the greater risk of contamination occurring to the environment .
  • the present invention seeks to overcome the problems associated with the prior art by providing apparatus that minimises the number of components used, so there is reduced waste material, in particular plastics waste material.
  • the invention also seeks to provide apparatus and a method of efficiently separating and extracting nucleic acid from biological samples, with minimal damage to the nucleic acid by providing a system that shears the nucleic acid from a magnetic bead-nucleic acid complex without causing the resultant long strands of nucleic acid to incur damage and which also provides for consistent re-suspension of material.
  • a closure member arranged to seat on a vessel formed of a chamber that can receive a sample from which material is to be separated, the closure member having an inlet aperture for introducing one or more reagents into the chamber, the closure member also having an elongate exit port which extends downwardly into the chamber such that material that is to be extracted from the chamber can be removed without the need to remove the closure member.
  • the material to be extracted is waste reagents or alternatively, the material may be the sample itself, in particular, once washed.
  • the closure member can be push fitted onto a vessel, or alternatively, a click-lock mechanism may be used to join the closure member with the open mouth of the vessel.
  • the closure member and vessel can be sealed together, for example by heat welding .
  • the inlet aperture is angled such that reagent introduced is directed against a sidewall of the vessel.
  • a lower wall forming the base of the vessel may have a stepped profile against which fluid or reagents entering the chamber may be directed to avoid the risk of splash back.
  • the inlet aperture is provided as an opening that can receive a pipette tip.
  • a seal arrangement may be provided over the opening that has to be broken by the pipette tip before material can be introduced into the vessel. This maintains the sterility of the vessel prior to use.
  • the inlet aperture may receive a pipette tip that is inserted in the aperture
  • the outlet port is an elongate aperture. This means that the aperture has a length that is longer than its width, with the length extending in the axis of the length of the chamber.
  • the seal is a plastic, rubber or metal material that is either pierce able or which has an area of weakness allowing the seal to be broken.
  • the inlet aperture may include a valve system, whereby material is introduced into a reservoir by the pipette and then the material is slowly released into the vessel by way of the valve mechanism which controls the flow of material flowing through the inlet aperture or port, into the vessel.
  • the inlet port may have a lid, which can be opened so that a sample can be introduced into the chamber and closed during incubation of the sample to reduce the risk of air-born contamination.
  • the exit port extends to be in proximity to a lower wall of the elongate chamber, said lower wall forming the base of the chamber.
  • the exit port which is advantageously provided as a pipette tip extends to approximately 0.5mm - 4mm above the base of the chamber.
  • the exit port extends into the vessel such that the outlet at the end of the exit port is substantially directed to the centre of the lower wall of the vessel.
  • the exit port may be to one or other side of the centre point of the lower wall.
  • the part of the exit port that is in communication with the closure member is provided with a seal, which forms a seal between the exit port and the closure member.
  • a preferred type of seal would be a ring seal.
  • the seal may be provided by way of a close tolerance moulding and having an integral moulding keeps manufacturing costs to a minimum.
  • a non-return valve associated with the upper portion of the exit port.
  • the valve may be provided by a ball, such as a steel ball, for example, a 3mm steel ball.
  • the valve operates to control the flow of material from the vessel through the exit port.
  • the exit port includes a filter to prevent contaminants from being extracted from the chamber with the material from the sample.
  • the filter is towards an upper portion of the exit port and may be located in the part of the exit port, which is contact with the body of the closure member.
  • the filter acts to prevent contaminants being drawn through the exit port, which again, reduces the risk of the sample obtained and the environment from being contaminated. This is especially important where sample from pathogenic microorganisms are being handled.
  • the filter is a hydrophilic filter to absorb any waste fluid passing through the exit port so there is a reduction is the risk of contamination.
  • the exit port preferably is in communication with a vacuum source to extract the sample material from the chamber.
  • a tube extends from the upper portion of the exit port is connected to the vacuum source.
  • the exit of the tube is in proximity to the filter and the vacuum maintains pressure on the filter such that substantially no material caught on the filter from the sample can return to the chamber.
  • the tube may include a viewing window so that the sample or waste that is being extracted can be observed as it exits the vessel .
  • waste material is dispensed into a waste receptacle in communication with the vacuum source.
  • the material from the sample is a nucleic acid material.
  • the nucleic acid may be DNA or RNA or any forms of such material for example mRNA.
  • the closure member is formed of a metal material such a stainless steel or aluminium. By having a metal rather than a plastics material the closure member can be sterilised, for example by autoclaving, thereby reducing further the production of contaminated waste material. Also by having a closure member that can be re-used, this reduces the costs of sampling material.
  • the exit port may also include a closure that can be sealed when the closure member is not in use.
  • a closure that can be sealed when the closure member is not in use.
  • exit port is formed integrally with the closure member.
  • a vessel having a base and upwardly extending walls to form a chamber for receiving a sample from which material is to be separated, the base including a channel extending along the base of the vessel, with two of said upwardly extending walls forming side walls for the channel and a further two of said side walls forming end walls of the channel, the channel including at least one ball that can travel along the channel to agitate material in the vessel .
  • the vessel is deeper than the width of the vessel.
  • the ends of the channel are curvilinear and extend to meet the end walls of the vessel.
  • the base of the vessel is inclined so that that ' sample material or material separated from the sample can collect at the bottom of said incline. This provides for ease of extraction of material from the vessel, for example by using a closure member having an exit port according to a first aspect of the invention.
  • the base of the container includes recesses for the collection of sample material.
  • the recess is between the part of the channel in proximity to an aperture at the end of an exit port extending into the vessel.
  • the channel includes at least one ball the can travel along the length of the channel.
  • the channel includes two or more balls.
  • the curved ends of the channel which are preferably or similar dimensions to the periphery for example correspond to the circumferential dimensions of the ball or balls, allows for maximum travel of the ball(s) along the channel .
  • the two or more balls are positioned in the channel either side of an aperture for the exit port .
  • the action of the ball or balls running along the narrow groove forming the channel provides a shearing action as the nucleic acid is pushed through the narrow gap between the ball(s) and the sidewalls and the base of the vessel.
  • the balls are caused to move by movement of the vessel within a carrier. Also there is break up of the nucleic acid as the ball hits the curved ends of the channel.
  • a further contributory factor is that the operation may be carried out at an elevated temperature, preferably 50-65 degrees centigrade. All these factors interact to re-suspend material so that a homogenous suspension is obtained. Poor suspension, which the current invention seeks to avoid, is when what can be seen as a "floating globule" occurs.
  • the balls are formed of stainless steel for example 316 non-magnetic stainless steel. It is preferred that the material from the sample is nucleic acid material.
  • the nucleic acid may be DNA or RNA or any forms of such material for example mRNA. It is envisaged that either the sidewall or a base of the vessel includes a profile, which may be a gradual slope, in proximity to the inlet aperture such that reagents entering the vessel hit the profiled surface of the vessel rather than the material in the base of the vessel and this reduces splash back of material in the vessel .
  • the vessel is adapted to be used with a closure member according to the invention.
  • a sample separation device comprising a closure member and a vessel formed of a chamber that can receive a sample from which material is to be separated, the closure member being adapted to seat on the vessel and having an inlet aperture for introducing one or more reagents into the chamber, the closure member also having an exit port which extends downwardly into the chamber such that material extracted from the chamber without the need to remove the closure member with the vessel, the chamber having a base and upwardly extending walls to form the chamber, the base including a channel extending along the base of the vessel, with two of said upwardly extending walls forming side walls for the channel and a further two of said side walls forming end walls of the channel, the channel including at least two balls one of the balls being on one side of the point at which the exit port extends into the vessel, the other of said balls being on the other side of the point at which the exit port open into the vessel, the balls
  • the ends of the channel are curvilinear and extend to meet the end walls of the vessel.
  • the curved ends of the channel which are preferably of similar dimensions to the periphery of the ball or balls allows for maximum travel of the ball (s) along the channel. It is envisaged that there is a small tolerance between the periphery of the ball(s) and the sidewalls forming the channel . Ideally there is a difference of 0.5mm between the width of the channel track and the diameter of the ball. This will mean that there is a clearance of 0.25mm either side of the ball in the channel .
  • Nucleic acids include not only DNA and/or RNA but also messenger or recombinant DNA can be sheared from a magnetic bead complex formed using the balls.
  • the balls are formed of stainless steel. It is preferred that the lower wall of the vessel forming the base includes a recess, preferably in proximity to the opening for the exit port. The recess allows for reagents or nucleic acid that has been separated from the magnetic bead complex to accumulate so that such material can be easily and cleanly withdrawn from the vessel through the exit port.
  • exit port extends into the vessel such that the outlet at the end of the exit port is substantially directed to the centre of the lower wall of the vessel.
  • closure member can be push fitted onto a vessel, or alternatively, a click-lock mechanism may be used or indeed the closure member and vessel can be sealed together.
  • the inlet aperture is angled such that reagent introduced is directed against a sidewall of the vessel.
  • a lower wall forming the base of the vessel may have a profile, which could be a step or a slope, against which fluid or reagents entering the chamber may be directed to avoid the risk of splash back.
  • the inlet aperture is provided as an opening that can receive a pipette tip and a seal arrangement may be provided over the opening.
  • the seal is a plastic, rubber or metal material that is either pierceable or which has an area of weakness allowing the seal to be broken.
  • the exit port extends to be in proximity to a lower wall of the elongate chamber, said lower wall forming the base of the chamber.
  • exit port is in sealed communication with the closure member.
  • a preferred type of seal would be a ring seal although the closure member may be moulded such that that no seal is needed.
  • the valve may be a ball valve.
  • the exit port includes a filter to prevent contaminants from being extracted from the chamber with the material from the sample .
  • the filter is a hydrophilic filter to absorb and wick away any waste fluid passing through the exit port .
  • the exit port preferably is connected to a vacuum source to extract the material such as reagents or sample from the chamber. Having a vacuum maintains pressure on the filter such that substantially no material caught on the filter from the sample can return to the chamber.
  • the vessel and/or closure member is formed of a metal material such a stainless steel or aluminium to allow for sterilization for re-use.
  • the inlet port and/or the exit port may have lids that can be sealed when the closure member is not in use so that the inside of the vessel can be maintained in a sterile condition.
  • a method for separating material from a sample wherein material is introduced into a chamber in which material is to be separated, the material is mixed with magnetic beads so allow material in the sample and the beads to complex, and placed in a magnetic field to attract the complex to a specific area in the vessel, balls are caused to travel along the channel there being a small tolerance between the walls of the channel and the balls to shear material in the complex from the beads.
  • the complex is preferably incubated before being subjected to treatment with a magnet.
  • the magnetic bead complex can be held in position while extraneous material such as haemoglobin and other proteins are removed into a waste container.
  • the complex can then be washed with buffers and the sample may be monitored for re-suspension. Material such as waste • or re-suspended material is removed at appropriate stages from the vessel by way of an exit port through which the material is extracted from the vessel.
  • the fourth aspect is carried out using equipment as described in previous aspects of the invention.
  • Figure Ia shows a plan view of a closure member according to a first aspect of the invention
  • Figure Ib shows a perspective view of the closure member of Figure Ia
  • Figure 2 shows a vessel having a channel that can be used with a closure member as shown in Figure Ia and Ib;
  • Figure 3 shows the closure member of Figure Ia or Figure Ib and the vessel of Figure 2 in combination;
  • Figure 4 shows an upper end of an exit port for the closure member, with a non-return valve and a filter
  • Figure 5 shows a further aspect of the invention including a vessel having balls within the channel at the base of a vessel;
  • Figure 6 shows the base of the vessel of Figure 5; and Figure 7: shows the vessel and lid of the first and second aspects of the invention supported in an automated carousel for harvesting nucleic acid.
  • the closure member comprises a main body, generally shown as 1 in Figure Ia.
  • the closure member has a series of four apertures 2 running along the length of the closure member 1. Although four apertures are shown, more than four or less than four apertures for example two, can be used depending upon how many vessels are to be associated with the closure member.
  • the exit ports are substantially central of the closure member with the inlet ports being to one side of the exit ports.
  • Each of the exit ports has a ring seal 4 to seat the respective exit port within the body of the closure member and within the exit port there is a valve 14.
  • the closure member has a flange or extension 5 which extends from underneath the closure member and this forms a seat which can sit within the mouth of a vessel as shown in Figure 2.
  • the vessel comprises a chamber 7 having a mouth 6 which can receive the extension 5 of the closure member.
  • the vessel may include a number of mouths which can be lined up with extensions 5 for a closure member which extends underneath a set of apertures which comprise an inlet aperture 2 and an exit port 3 in side- by-side relationship.
  • the vessel may have a lip 9 on one or both longitudinal sides which allow for the vessel to be seated within a carrier, for example a carousel for a series of vessels.
  • Running along the length of the base of each chamber is a channel 8.
  • Figure 3 shows in more detail a vessel having an inlet port 2 and in side-by-side relationship an exit port 3.
  • the exit port 3 includes an opening 10 which narrows to a tube like member 11 which extends into the body of the vessel.
  • the tube like member can be provided as an integral pipette tip.
  • the exit aperture of the tube 11 ends in proximity to the channel 8 at the base of the vessel.
  • the tube 11 extends to a point that is substantially equidistant from the two sides of the vessel.
  • the exit aperture of the tube is approximately 4mm from the bottom of the channel although this distance can vary for example between lmm and 6mm.
  • Figure 4 shows the upper portion of the exit port in more detail.
  • the exit port 3 has a sealing ring 4 which seals around the upper portion of the exit port which is in communication with closure member 1.
  • the exit port extends downwardly into the body of the closure member forming a first chamber 10.
  • the end walls of the chamber narrow to form an aperture which is narrower than the chamber 10 and in the neck of the aperture, there sits a valve member 14 which is shown in this case as a ball valve.
  • the ball valve is positioned above an exit tube which can include a filter member 15 beneath the ball valve.
  • the ball valve 14 controls the flow of fluid which is taken upwardly through the tube 11 and into chamber 10.
  • the filter 15 allows for the capture of any contaminated material in the sample to reduce the risk of environmental contamination and also to ensure that the sample that is extracted from the vessel is substantially pure.
  • the closure member of the first aspect of the invention can be used with a vessel of a second aspect of the invention.
  • the closure member 1 in this case is shown with the exit port being substantially central of the width of the closure member.
  • There is a vacuum tube 16 which is connected via a connection member 17 to the top of the closure member 1.
  • the vacuum tube 16 extends into chamber 10 which is positioned above valve 14.
  • the valve 14 sits above the entrance to tube 11 which extends downwardly into the body of the vessel.
  • the exit aperture 12 of the tube, which is cut at an angle to the length of the tube is in proximity to but does not come into total communication with the base of chamber 8.
  • Having a cut away portion of the end of the tube 11 provides a space between the end of the tube and the bottom of the chamber where material that has been extracted from a complex containing DNA, for example DNA strands can accumulate. Either side of the tube 11 can be found balls 18 which can travel between the side walls of the vessel and the tube 11.
  • the base of the vessel may include a sloped area with the profile of the lower wall of the vessel falling away to the lowest point being underneath the exit port 12 of the tip 11. This allows for a globule of extracted DNA 19 to accumulate in proximity to the tip so that the DNA can collect underneath the tip 11 so it can be extracted or reagents can be removed from the DNA as cleanly as possible.
  • blocks of closure members may be associated with corresponding vessels and seated in chambers 21 within a rotating carousel 22.
  • the combined closure member and vessel is shown as 20 in Figure 7.
  • each inlet aperture 200 ⁇ l of lysis buffer is dispensed, together with 200 ⁇ l of whole blood.
  • the blocks containing the blood and lysis buffer are positioned on the carousel as shown in Figure 7 and each block is identified with the correct sample number.
  • the carousel is programmed to gently shake the blood and lysis buffer for a period at room temperature, this period is usually five minutes and this is to release DNA from white blood cells .
  • the carousel may include means to gradually heat the sample to achieve optimum incubation conditions. A timer may also be included to time the period that incubation occurs.
  • the carousel may also include means to either heat up the reagents to stop a reaction or alternatively, cooling may occur to terminate the reaction, depending on the sample and/or reagents being used.
  • Magnetic beads are added together with a binding buffer and the carousel is again programmed to gently shake the blood and lysis buffer for a further five minutes at room temperature.
  • the carousel is positioned above an array of magnets so that DNA that has been complexed with magnetic beads is attracted to for example the bottom corner of a chamber. Supernatant is removed using a vacuum connected to the exit port and then wash buffer is added to a chamber using the inlet aperture which contains more lysis buffer.
  • the DNA bead complex is mixed vigorously to completely break up the complex into an even constituency.
  • a mixture for example ethanol or isopropynol is added to recombine the DNA onto the magnetic beads .
  • the vessel is then put within the magnetic field and supernatant is again removed.
  • Washing is repeated four times with decreasing amounts of lysis buffer and increasing amounts of alcohol at each stage.
  • the final wash involves removing last traces of alcohol by adding a final tris-HCL buffer wash at pH 8.5. Again, supernatant is removed using a vacuum connected to the exit port. It is possible to clean samples by including protein digestion enzyme to remove all traces of protein from DNA and heating the sample can accelerate the digestion process up to a point where the sample is cleaned and the protein digestion enzyme can then be deactivated by heat treatment so that further enzymatic reactions are not compromised.
  • the DNA/bead complex is broken up and re-suspended by the shearing action of DNA passing through the tip of the exit port .
  • the process of inclusion of magnetic beads and washing occurs as described in the first aspect of the invention.
  • the complex is broken up using balls travelling along a channel in the vessel in which the complex is contained.
  • the shearing action of removing DNA from the complex can be achieved by way of using one or more stainless steel balls which run along the narrow elongated horizontal trough as shown in Figures 5 and 6.
  • the elongated trough is approximately 30mm long with a width of 6.5mm.
  • the diameter of the ball running within the trough is 6mm.
  • the ball material is preferably, non-magnetic 316 stainless steel.
  • the action of the ball running along the narrow groove which forms the trough contributes to shearing action as nucleic acid is pushed through the narrow gap between the ball wall and bottom of the trough.
  • the balls are caused to move along the trough as a result of movement of the carousel or by manual movement, causing the balls to travel back and forth along the channel.
  • this elevated temperature as well as the impact of the ball hitting the end of the trough contributes to the shearing action and release of the nucleic acid from the complex.
  • the ball can be caused to move back and forth at six movements per second to cause shearing and the distance travelled back and forth is approximately 13.6mm.
  • the radial acceleration of the ball moving within the channel is 2.04m/second 2 .
  • the balls can move as a result of movement of the vessel in the carrier for example the balls are caused to move in a sideways back and forth movement as the vessels are shaken.
  • some of the DNA complex can stick to the balls can be caused to be broken up as the ball impacts against the sides of the vessel, the action of the chamber in which the ball is being shaken back and forth can result in the beads and DNA complex being broken up as the balls pass the DNA and beads complex thereby releasing DNA from the complex so that it can then be washed and extracted from the vessel .
  • the invention provides not only an improved method or introducing reagents into a vessel, but also an improved way of breaking up nucleic acid/carrier complexes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne un élément de fermeture (1) et un récipient présentant une chambre (7) qui forme un dispositif de séparation d'échantillon. L'élément de fermeture présente des ouvertures (2) qui peuvent être positionnées au-dessus de ports de sortie (3) possédant une ouverture (10) avec une extension (11) dans le corps du récipient. Un canal (8) s'étend sur la longueur de la base de chaque chambre, ledit canal pouvant recevoir des billes destinées à rompre des échantillons particuliers, notamment d'acide nucléique.
PCT/GB2006/003299 2005-09-06 2006-09-06 Appareil et procede de separation de matiere a partir d'echantillons biologiques WO2007028987A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06779318A EP1938108A2 (fr) 2005-09-06 2006-09-06 Appareil et procede de separation de matiere a partir d'echantillons biologiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0518073A GB2432667A (en) 2005-09-06 2005-09-06 Apparatus and method for the separation of material from biological samples
GB0518073.2 2005-09-06

Publications (2)

Publication Number Publication Date
WO2007028987A2 true WO2007028987A2 (fr) 2007-03-15
WO2007028987A3 WO2007028987A3 (fr) 2007-05-31

Family

ID=35220902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/003299 WO2007028987A2 (fr) 2005-09-06 2006-09-06 Appareil et procede de separation de matiere a partir d'echantillons biologiques

Country Status (3)

Country Link
EP (1) EP1938108A2 (fr)
GB (1) GB2432667A (fr)
WO (1) WO2007028987A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3187457A4 (fr) * 2014-08-27 2018-04-25 Hitachi High-Technologies Corporation Mécanisme de capture de particule par aspiration, et dispositif d'ouverture comprenant le mécanisme de capture de particule par aspiration

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202778A1 (en) * 2013-03-14 2014-10-02 Gen-Probe Incorporated Systems, methods, and apparatuses for performing automated reagent-based assays
DE102015221671B3 (de) * 2015-11-04 2016-08-04 Bob Kosier Gefäß für den Laboreinsatz
DE102016213060A1 (de) 2016-07-18 2018-01-18 Bob Kosier Gefäß für den Laboreinsatz

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3805788A (en) * 1972-12-20 1974-04-23 Bristol Myers Co Aspirator jar
US4013076A (en) * 1975-06-17 1977-03-22 Diemolding Corporation Aspirator jar
WO1983000228A1 (fr) * 1981-07-11 1983-01-20 Siegfried Jochimsen Appareil pour la mesure du temps de coagulation du sang et procede pour saisir et mesurer le temps
WO1989010787A1 (fr) * 1988-05-03 1989-11-16 Rhone Poulenc Chimie Tete de recipient pour la reaction chimique, le traitement ou l'analyse de produits divers et recipients en faisant application
US5272092A (en) * 1987-11-12 1993-12-21 Hitachi, Ltd. Method for analyzing a reaction solution
WO1998035758A1 (fr) * 1997-02-14 1998-08-20 Dendreon Corporation Dispositif de lavage de cellules et procede associe
US6382827B1 (en) * 2000-11-01 2002-05-07 Dade Behring Inc. Method and apparatus for mixing liquid solutions using a rotating magnet to generate a stirring vortex action
WO2002089725A2 (fr) * 2001-05-08 2002-11-14 Nexell Therapeutics Inc. Dispositifs de transfert de fluide et leurs procedes d'utilisation
US20020185457A1 (en) * 2001-06-06 2002-12-12 Emery Smith Centrifuge tube assembly
US20030126914A1 (en) * 2001-06-26 2003-07-10 Hvidtfeldt Kristian Jacob Blood analyzer, blood sample handler, and method for handling a blood sample
WO2005039773A1 (fr) * 2003-10-10 2005-05-06 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Contenant jetable pour centrifuger et pour traiter une matiere biologique fluide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1437561A (fr) * 1965-03-23 1966-05-06 Aquitaine Petrole Broyeur à sélection isogranulométrique automatique
GB8914456D0 (en) * 1989-06-23 1989-08-09 Radiometer As Apparatus for analysis of samples of fluids
IL110456A0 (en) * 1993-07-30 1994-10-21 Du Pont Apparatus for multiphase liquid separation
ZA200201853B (en) * 2002-03-06 2002-12-24 Hanekom Gideon Stephanus Homogeniser.
US7025935B2 (en) * 2003-04-11 2006-04-11 Illumina, Inc. Apparatus and methods for reformatting liquid samples
FI115060B (fi) * 2003-04-22 2005-02-28 Chip Man Technologies Oy Analyysi- ja kasvatuslaitteisto
CA2545135C (fr) * 2003-11-14 2013-01-08 Oakville Hong Kong Co., Limited Pot de prelevement d'echantillon a systeme d'analyse d'echantillon integre
FI117899B (fi) * 2004-07-09 2007-04-13 Chip Man Technologies Oy Solujen kasvatusalusta ja sen käyttö
GB2421448A (en) * 2004-12-24 2006-06-28 Levene Ltd William Foodstuff crushing and blending apparatus

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3805788A (en) * 1972-12-20 1974-04-23 Bristol Myers Co Aspirator jar
US4013076A (en) * 1975-06-17 1977-03-22 Diemolding Corporation Aspirator jar
WO1983000228A1 (fr) * 1981-07-11 1983-01-20 Siegfried Jochimsen Appareil pour la mesure du temps de coagulation du sang et procede pour saisir et mesurer le temps
US5272092A (en) * 1987-11-12 1993-12-21 Hitachi, Ltd. Method for analyzing a reaction solution
WO1989010787A1 (fr) * 1988-05-03 1989-11-16 Rhone Poulenc Chimie Tete de recipient pour la reaction chimique, le traitement ou l'analyse de produits divers et recipients en faisant application
WO1998035758A1 (fr) * 1997-02-14 1998-08-20 Dendreon Corporation Dispositif de lavage de cellules et procede associe
US6382827B1 (en) * 2000-11-01 2002-05-07 Dade Behring Inc. Method and apparatus for mixing liquid solutions using a rotating magnet to generate a stirring vortex action
WO2002089725A2 (fr) * 2001-05-08 2002-11-14 Nexell Therapeutics Inc. Dispositifs de transfert de fluide et leurs procedes d'utilisation
US20020185457A1 (en) * 2001-06-06 2002-12-12 Emery Smith Centrifuge tube assembly
US20030126914A1 (en) * 2001-06-26 2003-07-10 Hvidtfeldt Kristian Jacob Blood analyzer, blood sample handler, and method for handling a blood sample
WO2005039773A1 (fr) * 2003-10-10 2005-05-06 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Contenant jetable pour centrifuger et pour traiter une matiere biologique fluide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3187457A4 (fr) * 2014-08-27 2018-04-25 Hitachi High-Technologies Corporation Mécanisme de capture de particule par aspiration, et dispositif d'ouverture comprenant le mécanisme de capture de particule par aspiration
US10604393B2 (en) 2014-08-27 2020-03-31 Hitachi High-Technologies Corporation Particle suction capture mechanism and unstopping device equipped with particle suction capture mechanism

Also Published As

Publication number Publication date
EP1938108A2 (fr) 2008-07-02
GB0518073D0 (en) 2005-10-12
WO2007028987A3 (fr) 2007-05-31
GB2432667A (en) 2007-05-30

Similar Documents

Publication Publication Date Title
CA2646670C (fr) Appareil permettant de separer des particules magnetiques de liquides contenant lesdites particules, et reseau de cuves utilisable avec un tel appareil
JP5998218B2 (ja) 磁力体カバー及び核酸抽出装置
US7427510B2 (en) System for processing samples in a multichamber arrangement
US10472672B2 (en) Automatic response/light measurement device and method therefor
US9442127B2 (en) Sample processing device, sample processing method, and reaction container used in these device and method
JP3551293B2 (ja) 核酸抽出装置
EP2633328B1 (fr) Système automatisé de pcr en temps réel pour l'analyse de divers échantillons biologiques
EP2972406B1 (fr) Système et procédé pour la préparation automatisée d'échantillons
US20110009608A1 (en) Automatic refining apparatus, multi-well plate kit and method for extracting hexane from biological samples
US7329488B2 (en) Kit for separating and purifying nucleic acids or various biological materials, and system for automatically performing separation or purification of biological materials using the same
US20190226010A1 (en) Sample handling system with dosing device and thermal cycler
US8685322B2 (en) Apparatus and method for the purification of biomolecules
US10101354B2 (en) Method for prevention of contamination during disposing of liquid by pipet array
JPH119258A (ja) 使い捨て処理装置
JP2001070827A (ja) 核酸・蛋白質精製装置
EP1938108A2 (fr) Appareil et procede de separation de matiere a partir d'echantillons biologiques
JP5599488B2 (ja) 試料処理方法
EP2991558B1 (fr) Porte-échantillon pour l'analyse d'échantillons biologiques solides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006779318

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006779318

Country of ref document: EP